The Aptima HPV Assay is a diagnostic test designed to detect human papillomavirus (HPV) E6/E7 mRNA from 14 high-risk HPV types. It is used for cervical screening and is the first FDA-approved test for HPV mRNA. The test aims to provide fewer false-positive results in cervical cancer screening by targeting mRNA for high-risk HPV detection. Studies have shown that mRNA-based tests, like the Aptima HPV Assay, have equivalent sensitivity to DNA-based tests with superior specificity
. The HPV test is a screening test for cervical cancer that detects the presence of HPV, a virus that can lead to the development of genital warts, abnormal cervical cells, or cervical cancer. The Aptima HPV Assay specifically targets E6/E7 mRNA, which identifies the presence and activity of a high-risk HPV infection
. In summary, the Aptima HPV Assay is a sensitive and specific diagnostic test for the detection of high-risk HPV infections, particularly in the context of cervical cancer screening.
